Mallya automatically captures injection data (dose, date and time) and sends the information in real time to a mobile app thanks to Bluetooth technology. Moreover, the reported information is guaranteed with a high level of reliability.
Mallya received the CE IIb approval in 2019 and obtained 510(k) FDA clearance in 2022.